Blurred image
October 7, 2026
3 min read
Button to add Quantlake as preferred source on Google

Tactical Trends: Equal Weight Cracks, Equity Breadth Falls to 39%

Only 9 of 58 equity ETFs beat S&P 500 SPY at the close

Equal-weight and cyclical equity weakened on October 7. Only 23 of 59 equity ETFs (39%, -11.9pp) in our ETF universe are above their 20-day moving averages (20D MA), and 9 of 58 (16%, unchanged on the day) outperform the S&P 500 SPY. The 23pp price-relative gap leaves price participation ahead of relative leadership. Large-cap growth, Taiwan, and Brazil sit on the leader side; low-volatility, developed ex-US, and smaller-cap US equity form the laggard cluster.

Fixed income leadership is limited to short duration in price. Short-duration price breadth is 2 of 2, and long-duration price breadth is 0 of 1. Relative winners vs the Aggregate Bonds AGG center on short duration, high yield, and intermediate Treasuries. EM debt, preferreds, and long duration lag.

Specialty relative leadership vs the S&P 500 SPY is limited, with 5 of 15 names above their ratio MAs and strength centered on semiconductors and momentum. Gold, clean energy, and real estate lag. Commodity signals weakened, with Agriculture Basket DBA crossing below its 20D MA and silver in the laggard cluster.

20-Day Tactical Breadth

Line chart: share of equity, fixed income and specialty ETFs above their 20-day average, in price and relative to their benchmark, over 63 sessions to 7 Oct 2026; in price 39%, 12%, 47%; relative 16%, 56%, 33%

Key Takeaways

Ethereum ETHA, up 4.23% over the past 20 sessions, crossed below its 20D MA. Its relative line vs the S&P 500 SPY also crossed below its 20-day ratio moving average (20D ratio MA) after a 1.99% gain over the past 20 sessions.

Healthcare XLV crossed above its 20D MA. Equal Weight S&P 500 RSP and Small-Cap VB crossed below their 20D MA. S&P MidCap Growth MDYG crossed below its 20D ratio MA vs SPY.

Short Corporate VCSH and Short TIPS VTIP crossed above their 20D MA. TIPS TIP crossed above its 20D ratio MA vs AGG. Preferred Stock PFF crossed below its ratio moving average vs AGG.

Featured ETF: iShares Ethereum Trust ETF ETHA

Candlestick chart: ETHA price, daily, over 252 sessions to 7 Oct 2026, with its 20-day moving average; last 58.10, 2.0% below the average at 59.28

Technical Signals

Equity: Price vs 20-day MA

SignalTickerName20D perf
Cross-upXLVHealth Care Select Sector+1.73%
Cross-downACWViShares MSCI Global Min Vol Factor ETF-1.14%
Cross-downVWOVanguard FTSE Emerging Markets Index ETF-1.49%
Cross-downRSPInvesco S&P 500 Equal Weight ETF-1.51%
Cross-downXLIIndustrial Select Sector-2.04%
Cross-downVBVanguard Small-Cap Index ETF-2.13%
Cross-downIMTMiShares MSCI Intl Momentum Factor ETF-2.51%
Cross-downSLYGSPDR S&P 600 Small Cap Growth ETF-3.16%
Cross-downEWYiShares MSCI South Korea ETF-3.72%

Equity vs SPY: Price Ratio vs 20-day MA

SignalTickerName20D rel perf
Cross-upXLUUtilities Select Sector-5.54%
Cross-downMDYGSPDR S&P 400 Mid Cap Growth ETF-2.66%

Fixed Income: Price vs 20-day MA

SignalTickerName20D perf
Cross-upVTIPVanguard Short-Term Inflation-Protected Securities Index ETF-0.67%
Cross-upVCSHVanguard Short-Term Corporate Bond Index ETF-0.66%

Fixed Income vs AGG: Price Ratio vs 20-day MA

SignalTickerName20D rel perf
Cross-upTIPiShares TIPS Bond ETF-0.30%
Cross-downPFFiShares Preferred and Income Securities ETFunch.

Specialty: Price vs 20-day MA

SignalTickerName20D perf
Cross-downETHAiShares Ethereum Trust ETF+4.23%
Cross-downPAVEGlobal X U.S. Infrastructure Development ETF-1.66%
Cross-downICLNiShares Global Clean Energy ETF-3.89%

Specialty vs SPY: Price Ratio vs 20-day MA

SignalTickerName20D rel perf
Cross-downETHAiShares Ethereum Trust ETF+1.99%
Cross-downPAVEGlobal X U.S. Infrastructure Development ETF-3.77%

Commodities: Price vs 20-day MA

SignalTickerName20D perf
Cross-downDBAInvesco DB Agriculture-1.76%

Related


Romain Gandon
CEO, Quantlake

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

Share this article

More Research